Listed

Ardent Health, Inc.

ARDTNYSECIK 1756655HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.62bn, Q2 FY2026
Net income$16.9m, Q2 FY2026
Ardent Health, Inc., income statement, quarterly
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m1,378Revenue, period not labelled, three months to 2023-09-30$1.38bn. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figure1,346Revenue, period not labelled, three months to 2023-12-31$1.35bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-16, accession 0001628280-26-018174. Derived: 12-month figure less the 9-month figure.Report this figure1,439Revenue, period not labelled, three months to 2024-03-31$1.44bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-07, accession 0001628280-25-023210.Report this figure1,471Revenue, Q2 FY2024, three months to 2024-06-30$1.47bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-06, accession 0001756655-25-000018.Report this figure1,450Revenue, Q3 FY2024, three months to 2024-09-30$1.45bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure1,606Revenue, Q4 FY2024, three months to 2024-12-31$1.61bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-16, accession 0001628280-26-018174. Derived: 12-month figure less the 9-month figure.Report this figure1,497Revenue, Q1 FY2025, three months to 2025-03-31$1.50bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure1,645Revenue, Q2 FY2025, three months to 2025-06-30$1.65bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure1,577Revenue, Q3 FY2025, three months to 2025-09-30$1.58bn. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure1,605Revenue, Q4 FY2025, three months to 2025-12-31$1.61bn. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-16, accession 0001628280-26-018174. Derived: 12-month figure less the 9-month figure.Report this figure1,602Revenue, Q1 FY2026, three months to 2026-03-31$1.60bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure1,622Revenue, Q2 FY2026, three months to 2026-06-30$1.62bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure
Income tax$m7.3Income tax, period not labelled, three months to 2023-09-30$7.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figure(2.0)Income tax, period not labelled, three months to 2023-12-31−$2.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001628280-26-018174. Derived: 12-month figure less the 9-month figure.Report this figure10.7Income tax, period not labelled, three months to 2024-03-31$10.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-07, accession 0001628280-25-023210.Report this figure15.2Income tax, Q2 FY2024, three months to 2024-06-30$15.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0001756655-25-000018.Report this figure11.1Income tax, Q3 FY2024, three months to 2024-09-30$11.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure26.4Income tax, Q4 FY2024, three months to 2024-12-31$26.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001628280-26-018174. Derived: 12-month figure less the 9-month figure.Report this figure15.2Income tax, Q1 FY2025, three months to 2025-03-31$15.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure26.3Income tax, Q2 FY2025, three months to 2025-06-30$26.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure(3.4)Income tax, Q3 FY2025, three months to 2025-09-30−$3.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure18.1Income tax, Q4 FY2025, three months to 2025-12-31$18.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001628280-26-018174. Derived: 12-month figure less the 9-month figure.Report this figure16.1Income tax, Q1 FY2026, three months to 2026-03-31$16.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure8.5Income tax, Q2 FY2026, three months to 2026-06-30$8.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure
Net income$m20.8Net income, period not labelled, three months to 2023-09-30$20.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figure(4.2)Net income, period not labelled, three months to 2023-12-31−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001628280-26-018174. Derived: 12-month figure less the 9-month figure.Report this figure27.0Net income, period not labelled, three months to 2024-03-31$27.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure42.8Net income, Q2 FY2024, three months to 2024-06-30$42.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure26.3Net income, Q3 FY2024, three months to 2024-09-30$26.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure114Net income, Q4 FY2024, three months to 2024-12-31$114.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001628280-26-018174. Derived: 12-month figure less the 9-month figure.Report this figure41.4Net income, Q1 FY2025, three months to 2025-03-31$41.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure73.0Net income, Q2 FY2025, three months to 2025-06-30$73.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure(23.5)Net income, Q3 FY2025, three months to 2025-09-30−$23.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure45.0Net income, Q4 FY2025, three months to 2025-12-31$45.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001628280-26-018174. Derived: 12-month figure less the 9-month figure.Report this figure39.9Net income, Q1 FY2026, three months to 2026-03-31$39.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure16.9Net income, Q2 FY2026, three months to 2026-06-30$16.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure
Diluted EPS$ per share0.17Diluted EPS, period not labelled, three months to 2023-09-30$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figurenot reported0.21Diluted EPS, period not labelled, three months to 2024-03-31$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-07, accession 0001628280-25-023210.Report this figure0.34Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001756655-25-000018.Report this figure0.19Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figurenot reported0.29Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure0.52Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure(0.17)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figurenot reported0.28Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure0.12Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure
Basic EPS$ per share0.17Basic EPS, period not labelled, three months to 2023-09-30$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figurenot reported0.21Basic EPS, period not labelled, three months to 2024-03-31$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-07, accession 0001628280-25-023210.Report this figure0.34Basic EPS, Q2 FY2024, three months to 2024-06-30$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001756655-25-000018.Report this figure0.19Basic EPS, Q3 FY2024, three months to 2024-09-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figurenot reported0.30Basic EPS, Q1 FY2025, three months to 2025-03-31$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure0.52Basic EPS, Q2 FY2025, three months to 2025-06-30$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure(0.17)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figurenot reported0.28Basic EPS, Q1 FY2026, three months to 2026-03-31$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure0.12Basic EPS, Q2 FY2026, three months to 2026-06-30$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure

Balance sheet

Cash and equivalents$724.5m, Q2 FY2026
Long-term debt$1.07bn, Q2 FY2026
Shareholders' equity$1.35bn, Q2 FY2026
Ardent Health, Inc., balance sheet, quarterly
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported438Cash and equivalents, period not labelled, at 2023-12-31$437.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0001628280-25-008727.Report this figurenot reported335Cash and equivalents, Q2 FY2024, at 2024-06-30$334.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001628280-24-037278.Report this figure563Cash and equivalents, Q3 FY2024, at 2024-09-30$563.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figure557Cash and equivalents, FY2024, at 2024-12-31$556.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-16, accession 0001628280-26-018174.Report this figure495Cash and equivalents, Q1 FY2025, at 2025-03-31$495.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-07, accession 0001628280-25-023210.Report this figure541Cash and equivalents, Q2 FY2025, at 2025-06-30$540.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001756655-25-000018.Report this figure609Cash and equivalents, Q3 FY2025, at 2025-09-30$609.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure710Cash and equivalents, FY2025, at 2025-12-31$709.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure610Cash and equivalents, Q1 FY2026, at 2026-03-31$609.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure724Cash and equivalents, Q2 FY2026, at 2026-06-30$724.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure
Current assets$mnot reported1,618Current assets, period not labelled, at 2023-12-31$1.62bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0001628280-25-008727.Report this figurenot reported1,501Current assets, Q2 FY2024, at 2024-06-30$1.50bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001628280-24-037278.Report this figure1,691Current assets, Q3 FY2024, at 2024-09-30$1.69bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figure1,833Current assets, FY2024, at 2024-12-31$1.83bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-16, accession 0001628280-26-018174.Report this figure1,761Current assets, Q1 FY2025, at 2025-03-31$1.76bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-07, accession 0001628280-25-023210.Report this figure1,877Current assets, Q2 FY2025, at 2025-06-30$1.88bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001756655-25-000018.Report this figure1,957Current assets, Q3 FY2025, at 2025-09-30$1.96bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure2,059Current assets, FY2025, at 2025-12-31$2.06bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure2,020Current assets, Q1 FY2026, at 2026-03-31$2.02bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure2,055Current assets, Q2 FY2026, at 2026-06-30$2.05bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure
Total assets$mnot reported4,732Total assets, period not labelled, at 2023-12-31$4.73bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0001628280-25-008727.Report this figurenot reported4,609Total assets, Q2 FY2024, at 2024-06-30$4.61bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001628280-24-037278.Report this figure4,800Total assets, Q3 FY2024, at 2024-09-30$4.80bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figure4,956Total assets, FY2024, at 2024-12-31$4.96bn. XBRL concept us-gaap:Assets. 10-K filed 2026-03-16, accession 0001628280-26-018174.Report this figure4,911Total assets, Q1 FY2025, at 2025-03-31$4.91bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-07, accession 0001628280-25-023210.Report this figure5,027Total assets, Q2 FY2025, at 2025-06-30$5.03bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001756655-25-000018.Report this figure5,154Total assets, Q3 FY2025, at 2025-09-30$5.15bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure5,290Total assets, FY2025, at 2025-12-31$5.29bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure5,253Total assets, Q1 FY2026, at 2026-03-31$5.25bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure5,280Total assets, Q2 FY2026, at 2026-06-30$5.28bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure
Current liabilities$mnot reported994Current liabilities, period not labelled, at 2023-12-31$994.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0001628280-25-008727.Report this figurenot reported909Current liabilities, Q2 FY2024, at 2024-06-30$908.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001628280-24-037278.Report this figure887Current liabilities, Q3 FY2024, at 2024-09-30$887.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figure945Current liabilities, FY2024, at 2024-12-31$945.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-16, accession 0001628280-26-018174.Report this figure830Current liabilities, Q1 FY2025, at 2025-03-31$830.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-07, accession 0001628280-25-023210.Report this figure881Current liabilities, Q2 FY2025, at 2025-06-30$880.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001756655-25-000018.Report this figure943Current liabilities, Q3 FY2025, at 2025-09-30$943.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure1,047Current liabilities, FY2025, at 2025-12-31$1.05bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure951Current liabilities, Q1 FY2026, at 2026-03-31$951.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure976Current liabilities, Q2 FY2026, at 2026-06-30$976.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure
Total liabilities$mnot reported3,649Total liabilities, period not labelled, at 2023-12-31$3.65bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0001628280-25-008727.Report this figurenot reported3,446Total liabilities, Q2 FY2024, at 2024-06-30$3.45bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001628280-24-037278.Report this figure3,413Total liabilities, Q3 FY2024, at 2024-09-30$3.41bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figure3,434Total liabilities, FY2024, at 2024-12-31$3.43bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-16, accession 0001628280-26-018174.Report this figure3,347Total liabilities, Q1 FY2025, at 2025-03-31$3.35bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-07, accession 0001628280-25-023210.Report this figure3,381Total liabilities, Q2 FY2025, at 2025-06-30$3.38bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001756655-25-000018.Report this figure3,523Total liabilities, Q3 FY2025, at 2025-09-30$3.52bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure3,605Total liabilities, FY2025, at 2025-12-31$3.61bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure3,522Total liabilities, Q1 FY2026, at 2026-03-31$3.52bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure3,539Total liabilities, Q2 FY2026, at 2026-06-30$3.54bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure
Long-term debt$mnot reported1,168Long-term debt, period not labelled, at 2023-12-31$1.17bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-27, accession 0001628280-25-008727.Report this figurenot reported1,082Long-term debt, Q2 FY2024, at 2024-06-30$1.08bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-14, accession 0001628280-24-037278.Report this figure1,084Long-term debt, Q3 FY2024, at 2024-09-30$1.08bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figure1,086Long-term debt, FY2024, at 2024-12-31$1.09bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-16, accession 0001628280-26-018174.Report this figure1,091Long-term debt, Q1 FY2025, at 2025-03-31$1.09bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-07, accession 0001628280-25-023210.Report this figure1,090Long-term debt, Q2 FY2025, at 2025-06-30$1.09bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-06, accession 0001756655-25-000018.Report this figure1,087Long-term debt, Q3 FY2025, at 2025-09-30$1.09bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure1,076Long-term debt, FY2025, at 2025-12-31$1.08bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure1,073Long-term debt, Q1 FY2026, at 2026-03-31$1.07bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure1,073Long-term debt, Q2 FY2026, at 2026-06-30$1.07bn. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure
Current portion of debt$mnot reported18.6Current portion of debt, period not labelled, at 2023-12-31$18.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-27, accession 0001628280-25-008727.Report this figurenot reported10.7Current portion of debt, Q2 FY2024, at 2024-06-30$10.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-14, accession 0001628280-24-037278.Report this figure12.2Current portion of debt, Q3 FY2024, at 2024-09-30$12.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figure9.2Current portion of debt, FY2024, at 2024-12-31$9.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-16, accession 0001628280-26-018174.Report this figure17.8Current portion of debt, Q1 FY2025, at 2025-03-31$17.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-07, accession 0001628280-25-023210.Report this figure19.3Current portion of debt, Q2 FY2025, at 2025-06-30$19.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-06, accession 0001756655-25-000018.Report this figure19.3Current portion of debt, Q3 FY2025, at 2025-09-30$19.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure23.4Current portion of debt, FY2025, at 2025-12-31$23.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure37.6Current portion of debt, Q1 FY2026, at 2026-03-31$37.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure28.6Current portion of debt, Q2 FY2026, at 2026-06-30$28.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure
Shareholders' equity$m1,084Shareholders' equity, period not labelled, at 2023-09-30$1.08bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figure671Shareholders' equity, period not labelled, at 2023-12-31$670.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-02-27, accession 0001628280-25-008727.Report this figure1,110Shareholders' equity, period not labelled, at 2024-03-31$1.11bn. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure740Shareholders' equity, Q2 FY2024, at 2024-06-30$739.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-14, accession 0001628280-24-037278.Report this figure1,006Shareholders' equity, Q3 FY2024, at 2024-09-30$1.01bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figure1,131Shareholders' equity, FY2024, at 2024-12-31$1.13bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-16, accession 0001628280-26-018174.Report this figure1,175Shareholders' equity, Q1 FY2025, at 2025-03-31$1.18bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-07, accession 0001628280-25-023210.Report this figure1,255Shareholders' equity, Q2 FY2025, at 2025-06-30$1.25bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-06, accession 0001756655-25-000018.Report this figure1,238Shareholders' equity, Q3 FY2025, at 2025-09-30$1.24bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure1,288Shareholders' equity, FY2025, at 2025-12-31$1.29bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure1,337Shareholders' equity, Q1 FY2026, at 2026-03-31$1.34bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure1,351Shareholders' equity, Q2 FY2026, at 2026-06-30$1.35bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure

Cash flow

Operating cash flow$196.7m, Q2 FY2026
Ardent Health, Inc., cash flow, quarterly
Line itemUnitperiod not labelled2023-09-30period not labelled2023-12-31period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m88.7Operating cash flow, period not labelled, three months to 2023-09-30$88.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001756655-24-000017. Derived: 9-month figure less the 6-month figure.Report this figure67.5Operating cash flow, period not labelled, three months to 2023-12-31$67.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001628280-26-018174. Derived: 12-month figure less the 9-month figure.Report this figure(14.7)Operating cash flow, period not labelled, three months to 2024-03-31−$14.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-07, accession 0001628280-25-023210.Report this figure120Operating cash flow, Q2 FY2024, three months to 2024-06-30$120.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001756655-25-000018. Derived: 6-month figure less the 3-month figure.Report this figure89.7Operating cash flow, Q3 FY2024, three months to 2024-09-30$89.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001628280-25-052362. Derived: 9-month figure less the 6-month figure.Report this figure120Operating cash flow, Q4 FY2024, three months to 2024-12-31$119.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001628280-26-018174. Derived: 12-month figure less the 9-month figure.Report this figure(24.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$24.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure117Operating cash flow, Q2 FY2025, three months to 2025-06-30$117.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001628280-26-055215. Derived: 6-month figure less the 3-month figure.Report this figure154Operating cash flow, Q3 FY2025, three months to 2025-09-30$154.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001628280-25-052362. Derived: 9-month figure less the 6-month figure.Report this figure223Operating cash flow, Q4 FY2025, three months to 2025-12-31$223.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001628280-26-018174. Derived: 12-month figure less the 9-month figure.Report this figure(60.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$60.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure197Operating cash flow, Q2 FY2026, three months to 2026-06-30$196.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001628280-26-055215. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)143.05m, Q2 FY2026
Ardent Health, Inc., shares, quarterly
Line itemUnitperiod not labelled2023-06-30period not labelled2023-09-30period not labelled2024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares126Diluted shares (weighted), period not labelled, three months to 2023-06-30126,115,301 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001628280-24-037278.Report this figure126Diluted shares (weighted), period not labelled, three months to 2023-09-30126,115,301 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001756655-24-000017.Report this figure126Diluted shares (weighted), period not labelled, three months to 2024-03-31126,115,301 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-07, accession 0001628280-25-023210.Report this figure126Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30126,115,301 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001756655-25-000018.Report this figure138Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30137,542,995 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure141Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31140,704,075 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure142Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30141,517,661 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure141Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30141,226,862 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001628280-25-052362.Report this figure142Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31141,775,040 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001628280-26-031299.Report this figure143Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30143,052,519 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure

Shares outstanding: 141.05mShares outstanding, period not labelled, at 2026-08-07141,045,907 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-10, accession 0001628280-26-055215.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 10, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.